Physician profile
Christopher Ross
NPI 1245268630
$14,526.80
in general payments reported to CMS, 2019-2025
5 companies · $34.49 in 2025
The $34.49 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,114 · 2022: $5,172 · 2024: $3,206 · 2025: $34.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,105 · Food and Beverage: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,105.00 |
| Food and Beverage | $135.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| F. Hoffmann-La Roche Ag | $9,277.61 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $4,100.00 | 2022 | |
| Sage Therapeutics, LLC | $1,072.00 | 2022 | |
| Hoffmann-La Roche Limited | $42.70 | 2019 | |
| Gilead Sciences, INC. | $34.49 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.